Skip to main content

Keel Point, LLC

SEC CIK
0001386935
Latest filing
Aug 14, 2026

NVS holding history

Novartis AG in every 13F filed by Keel Point, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
6,229
Value
$976.2K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of NVS by Keel Point, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,229$976.2K0.1%+214+3.6%AddedHolders
Q1 20266,015$918.8K0.1%−2,066−25.6%ReducedHolders
Q4 20258,081$1.11M0.1%+20.0%AddedHolders
Q3 20258,079$1.04M0.1%+333+4.3%AddedHolders
Q2 20257,746$937.3K0.1%+872+12.7%AddedHolders
Q1 20256,874$766.3K0.1%+183+2.7%AddedHolders
Q4 20246,691$651.1K0.1%−856−11.3%ReducedHolders
Q3 20247,547$868.1K0.1%−188−2.4%ReducedHolders
Q2 20247,735$870.5K0.1%+4,221+120.1%AddedHolders
Q1 20243,514$339.9K<0.1%+868+32.8%AddedHolders
Q4 20232,646$267.2K<0.1%+73+2.8%AddedHolders
Q3 20232,573$262.1K<0.1%−110−4.1%ReducedHolders
Q2 20232,683$270.8K<0.1%+44+1.7%AddedHolders
Q1 20232,639$242.8K<0.1%−357−11.9%ReducedHolders
Q4 20222,996$271.8K<0.1%+211+7.6%AddedHolders
Q3 20222,785$212.0K<0.1%−77−2.7%ReducedHolders
Q2 20222,862$250.0K<0.1%+131+4.8%AddedHolders
Q1 20222,731$240.0K<0.1%−177−6.1%ReducedHolders
Q4 20212,908$254.0K<0.1%−601−17.1%ReducedHolders
Q3 20213,509$287.0K<0.1%+47+1.4%AddedHolders
Q2 20213,462$316.0K<0.1%−306−8.1%ReducedHolders
Q1 20213,768$322.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.